EP3551664
Mótefni og fjölpeptíð sem beinast gegn CD127
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.12.2017EP published:
17.2.2021EP application number:
17835592.1
EP translation filed:
13.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
6.12.2037Expiry date:
6.12.2026Next due date:
31.12.2026
Title:
ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
Timeline
Today
7.12.2017EP application
17.2.2021EP Publication
13.4.2021Translation submitted
15.5.2021Registration published
6.12.2026Expires
Owner
Name:
OSE ImmunotherapeuticsAddress:
22 Boulevard Benoni Goullin, 44200 Nantes, FR
Inventor
Name:
POIRIER, NicolasAddress:
44119 Treillieres, FR
Name:
MARY, CarolineAddress:
44680 Sainte-Pazanne, FR
Name:
VANHOVE, BernardAddress:
44400 Reze, FR
Name:
THEPENIER, VirginieAddress:
44680 Sainte Pazanne, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16306655Date:
9.12.2016Country:
EP
Classification
Categories:
C07K 16/28, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 18.11.2021
Expires: 6.12.2022
Payer: Acumass
Number: 6
Paid: 16.11.2022
Expires: 6.12.2023
Payer: Acumass
Number: 7
Paid: 17.11.2023
Expires: 6.12.2024
Payer: Acumass
Number: 8
Paid: 20.11.2024
Expires: 6.12.2025
Payer: Acumass
Number: 9
Paid: 21.11.2025
Expires: 6.12.2026
Payer: Acumass